日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety, Efficacy, and Patient-Reported Outcomes From a Phase 2 Randomized Trial of Pozelimab and Cemdisiran Combination in Patients With Paroxysmal Nocturnal Hemoglobinuria

一项评估波泽利单抗和西美沙酮联合治疗阵发性睡眠性血红蛋白尿患者的 II 期随机试验的安全性、有效性和患者报告结局

Jang, Jun-Ho; Wong, Raymond Siu Ming; Hartford, Christopher; Pavani, Rodrigo; Aurand, Lisa; Nguyen, Quang; Mohan, Kosalai; Meagher, Karoline; Sherman, Steven; Rofail, Diana; Perlee, Lorah; Souttou, Amal; Kelly, Richard J

Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trial

在 II 期临床试验中,接受 cemiplimab 治疗的局部晚期基底细胞癌患者的生活质量

Stratigos, Alexander J; Chen, Chieh-I; Ivanescu, Cristina; Lewis, Karl D; Peris, Ketty; Bechter, Oliver; Harnett, James; Mastey, Vera; Reaney, Matthew; Daskalopoulou, Christina; LaFontaine, Patrick R; Konidaris, Gerasimos; Bury, Denise; Yoo, Suk-Young; Mohan, Kosalai; Coates, Ebony; Bowler, Timothy; Fury, Matthew G; Sekulic, Aleksandar

HnRNPK maintains single strand RNA through controlling double-strand RNA in mammalian cells

HnRNPK通过调控哺乳动物细胞中的双链RNA来维持单链RNA的稳定性。

Sagar Mahale,Meenakshi Setia,Bharat Prajapati,Santhilal Subhash,Mukesh Pratap Yadav,Subazini Thankaswamy Kosalai,Ananya Deshpande,Jagannath Kuchlyan,Mirco Di Marco,Fredrik Westerlund,L Marcus Wilhelmsson,Chandrasekhar Kanduri #,Meena Kanduri #

Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Cemiplimab、放射疗法、环磷酰胺和粒细胞巨噬细胞集落刺激因子治疗复发或转移性头颈部鳞状细胞癌患者的I期临床试验

Babiker, Hani; Brana, Irene; Mahadevan, Daruka; Owonikoko, Taofeek; Calvo, Emiliano; Rischin, Danny; Moreno, Victor; Papadopoulos, Kyriakos P; Crittenden, Marka; Formenti, Silvia; Giralt, Jordi; Garrido, Pilar; Soria, Ainara; Hervás-Morón, Asunción; Mohan, Kosalai Kal; Fury, Matthew; Lowy, Israel; Mathias, Melissa; Feng, Minjie; Li, Jingjin; Stankevich, Elizabeth

NBAT1/CASC15-003/USP36 control MYCN expression and its downstream pathway genes in neuroblastoma

NBAT1/CASC15-003/USP36 控制神经母细胞瘤中 MYCN 表达及其下游通路基因

Prasanna Kumar Juvvuna, Tanmoy Mondal, Mirco Di Marco, Subazini Thankaswamy Kosalai, Meena Kanduri, Chandrasekhar Kanduri

The DNA damage inducible lncRNA SCAT7 regulates genomic integrity and topoisomerase 1 turnover in lung adenocarcinoma

DNA 损伤诱导的 lncRNA SCAT7 调节肺腺癌中的基因组完整性和拓扑异构酶 1 的周转

Luisa Statello, Mohamad M Ali, Silke Reischl, Sagar Mahale, Subazini Thankaswamy Kosalai, Maite Huarte, Chandrasekhar Kanduri

EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia

EZH2 通过 IGF1R 和 MYC 上调临床侵袭性慢性淋巴细胞白血病中的 PI3K/AKT 通路

Subazini Thankaswamy Kosalai, Mohammad Hamdy Abdelrazak Morsy, Nikos Papakonstantinou, Larry Mansouri, Niki Stavroyianni, Chandrasekhar Kanduri, Kostas Stamatopoulos, Richard Rosenquist, Meena Kanduri

PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers

对 S 期富集的 lncRNA 进行 PAN 癌症分析,可识别致癌驱动因素和生物标志物

Mohamad Moustafa Ali, Vijay Suresh Akhade, Subazini Thankaswamy Kosalai, Santhilal Subhash, Luisa Statello, Matthieu Meryet-Figuiere, Jonas Abrahamsson, Tanmoy Mondal, Chandrasekhar Kanduri

Early onset of inflammation during ontogeny of bipolar disorder: the NLRP2 inflammasome gene distinctly differentiates between patients and healthy controls in the transition between iPS cell and neural stem cell stages

双相情感障碍个体发育过程中炎症的早期发生:NLRP2 炎症小体基因在 iPS 细胞和神经干细胞阶段的过渡过程中明显区分了患者和健康对照者

D Vizlin-Hodzic, Q Zhai, S Illes, K Södersten, K Truvé, T Z Parris, P K Sobhan, S Salmela, S T Kosalai, C Kanduri, J Strandberg, H Seth, T O Bontell, E Hanse, H Ågren, K Funa

Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL

全球DNA甲基化谱分析揭示了慢性淋巴细胞白血病中表观遗传失调的蛋白质编码和长链非编码RNA的新见解

Subhash, Santhilal; Andersson, Per-Ola; Kosalai, Subazini Thankaswamy; Kanduri, Chandrasekhar; Kanduri, Meena